GW Pharmaceuticals Plc (GWP)-医療機器分野:企業M&A・提携分析

◆英語タイトル:GW Pharmaceuticals Plc (GWP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011095
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the treatment of spasticity due to multiple sclerosis. It sells and distributes the product through strategic collaborations with other pharmaceutical companies. GW Pharmaceuticals is also developing other products that are focused at treating Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis, infantile spasms, epilepsy, glioma, schizophrenia, autism among others. The company along with its subsidiaries operates in the US, England and Wales. GW Pharmaceuticals is headquartered in Cambridgeshire, the UK.

GW Pharmaceuticals Plc (GWP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GW Pharmaceuticals Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GW Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
GW Pharmaceuticals Plc, Medical Equipment, Deal Details 10
Private Equity 10
Mentor Capital Invests USD1 Million in GW Pharma 10
Equity Offering 11
GW Pharma Raises USD317.4 Million in Public Offering of Shares 11
GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 13
GW Pharma Completes Public Offering Of American Depositary Shares For US$101 Million 15
Acquisition 17
GW Pharma May Sell Itself 17
GW Pharmaceuticals Plc – Key Competitors 18
GW Pharmaceuticals Plc – Key Employees 19
GW Pharmaceuticals Plc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 07, 2017: GW Pharmaceuticals Reports Fiscal Third Quarter 2017 Financial Results 21
May 09, 2017: GW Pharmaceuticals Reports Fiscal Second Quarter 2017 Financial Results and Operational Progress 23
Feb 07, 2017: GW Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Progress 25
Dec 05, 2016: GW Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress 26
Aug 09, 2016: GW Pharmaceuticals Reports Third Quarter 2016 Financial Results and Operational Progress 27
May 05, 2016: GW Pharmaceuticals Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress 28
Feb 10, 2016: GW Pharmaceuticals Reports First Quarter 2016 Financial Results and Operational Progress 29
Corporate Communications 30
May 15, 2017: GW Pharmaceuticals Announces Research & Development Management Appointments 30
Mar 07, 2017: GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director – UK 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
GW Pharmaceuticals Plc, Medical Equipment, Key Facts, 2016 2
GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GW Pharmaceuticals Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GW Pharmaceuticals Plc, Deals By Market, 2011 to YTD 2017 8
GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Mentor Capital Invests USD1 Million in GW Pharma 10
GW Pharma Raises USD317.4 Million in Public Offering of Shares 11
GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 13
GW Pharma Completes Public Offering Of American Depositary Shares For US$101 Million 15
GW Pharma May Sell Itself 17
GW Pharmaceuticals Plc, Key Competitors 18
GW Pharmaceuticals Plc, Key Employees 19
GW Pharmaceuticals Plc, Other Locations 20
GW Pharmaceuticals Plc, Subsidiaries 20

★海外企業調査レポート[GW Pharmaceuticals Plc (GWP)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Citigroup Inc:企業の戦略・SWOT・財務情報
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • QBE Insurance (Vietnam) Company Ltd:企業の戦略的SWOT分析
    QBE Insurance (Vietnam) Company Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Cogeco Inc:企業の戦略・SWOT・財務情報
    Cogeco Inc - Strategy, SWOT and Corporate Finance Report Summary Cogeco Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cellular Biomedicine Group Inc (CBMG):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellular Biomedicine Group Inc (CBMG) is a clinical stage biopharmaceutical firm that develops biomedicine, immunotherapy products for cancer and stem cell therapies to address patient specific medical conditions. The firm’s products comprise clinical treatment protocols for the treatment of …
  • Diffusion Pharmaceuticals Inc (DFFN):企業の財務・戦略的SWOT分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • 2020 GeneSystems Inc-医療機器分野:企業M&A・提携分析
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. The company provides tests in the areas such as personalized medicine, earl …
  • Steel Reef Infrastructure Corp-石油・ガス分野:企業M&A・提携分析
    Summary Steel Reef Infrastructure Corp (Steel Reef) is a mid-stream company that focuses on long-term returns through investments in small to midsized infrastructure with focus on the Western Canadian Sedimentary Basin. The company carries out the construction, operation and optimization of oil and …
  • EP Energy Corp (EPE):石油・ガス:M&Aディール及び事業提携情報
    Summary EP Energy Corp (EP Energy) is an oil and gas exploration and production company that offers acquisition and development of unconventional onshore oil and natural gas properties in the US. The company operates Altamont program, Eagle Ford program and Wolfcamp program. Its Eagle Ford program i …
  • LifeAssays AB (LIFE B)-医療機器分野:企業M&A・提携分析
    Summary LifeAssays AB (LifeAssays) is a medical device company that develops, manufactures and markets in-vitro diagnostic and veterinary care products. The company provides point-of-care diagnostic testing systems. Its product portfolio includes lifeassays human system and lifeassays veterinary sys …
  • Emergent BioSolutions Inc (EBS):企業の財務・戦略的SWOT分析
    Emergent BioSolutions Inc (EBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Meridian Energy Ltd (MEL):企業の財務・戦略的SWOT分析
    Meridian Energy Ltd (MEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Statkraft AS-エネルギー分野:企業M&A・提携分析
    Summary Statkraft AS (Statkraft), a subsidiary of Statkraft SF, is a power utility which produces electricity and thermal energy. It generates power from hydro, wind, gas, and bio-power sources. The company develops hydroelectric power plants across various countries. Statkraft trades and originates …
  • Shv Holdings N.V.
    Shv Holdings N.V. - Strategy, SWOT and Corporate Finance Report Summary Shv Holdings N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bio-Rad Laboratories, Inc.:戦略・SWOT・企業財務分析
    Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that offers laboratory services. The laboratory’s services include picogram-level bioanalytical method development and validation, analytical and bioanalytical support for ADME studies, and analytical and bioanalytical support for pharma …
  • T-Mobile Netherlands Holding B.V.:企業の戦略的SWOT分析
    T-Mobile Netherlands Holding B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • HeartSciences:医療機器:M&Aディール及び事業提携情報
    Summary HeartSciences, formerly Heart Test Laboratories Inc, is a medical device company that offers cardiac care products. The company develops, manufactures and markets cardiac testing tools for the early detection of heart disease. It offers MyoVista, a screening tool used to determine the presen …
  • Bioversys AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Bioversys AG (Bioversys) is a biotechnology company that researches and develops small molecules which turn off drug resistance against existing antibiotics. The company employs proprietary transcriptional regulator inhibitory compounds (TRIC) technology for screening, identifying and develo …
  • RegenxBio Inc (RGNX):企業の財務・戦略的SWOT分析
    RegenxBio Inc (RGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆